Reports for NATCO PHARMA (CANADA) INC

Company Name

NATCO PHARMA (CANADA) INC

Totals

Shortage reports

56
Actual shortage: 30 (54%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 26 (46%)

Discontinuation Reports

0
To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

1 (2%)

Overdue reports

1 (3%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NAT-ERLOTINIB 150MG TABLET Actual shortage 2020-12-03 2024-12-16 129553
NAT-ESCITALOPRAM 10MG TABLET Resolved 2019-02-15 2020-10-26 75793
NAT-ESCITALOPRAM 20MG TABLET Resolved 2019-02-15 2020-10-26 75799
NAT-ESCITALOPRAM 20MG TABLET Resolved 2024-02-02 2024-05-10 218258
NAT-EVEROLIMUS 2.5MG TABLET Resolved 2024-04-29 2025-07-04 226575
NAT-EVEROLIMUS 5MG TABLET Resolved 2024-11-01 2025-07-04 241865
NAT-EVEROLIMUS 10MG TABLET Resolved 2024-11-01 2025-07-04 241868
NAT-GEFITINIB 250MG TABLET Actual shortage 2025-04-04 2025-07-03 254195
NAT-IMATINIB 100MG TABLET Resolved 2024-08-30 2025-07-24 236421
NAT-IMATINIB 400MG TABLET Resolved 2024-08-30 2025-07-24 236418
NAT-LEVETIRACETAM 250MG TABLET Resolved 2019-02-15 2022-07-01 75810
NAT-LEVETIRACETAM 250MG TABLET Actual shortage 2025-06-25 2025-07-03 261126
NAT-LEVETIRACETAM 500MG TABLET Resolved 2018-10-19 2020-10-26 64878
NAT-LEVETIRACETAM 500MG TABLET Actual shortage 2025-06-25 2025-07-03 261129
NAT-LEVETIRACETAM 750MG TABLET Resolved 2019-04-17 2021-10-15 81921
NAT-LEVETIRACETAM 750MG TABLET Actual shortage 2025-04-04 2025-07-03 254205
NAT-MONTELUKAST 4MG TABLET (CHEWABLE) Actual shortage 2024-04-29 2025-06-03 226579
NAT-MONTELUKAST 5MG TABLET (CHEWABLE) Actual shortage 2024-04-29 2025-06-03 226582
NAT-MONTELUKAST 10MG TABLET Actual shortage 2025-06-25 2025-07-03 261132
NAT-OMEPRAZOLE DR 20MG TABLET (DELAYED-RELEASE) Actual shortage 2024-06-13 2025-07-03 230400

Showing 21 to 40 of 56

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0